Glenmark Pharmaceuticals Limited has submitted the transcript of its earnings call to the National Stock Exchange of India Limited and BSE Limited. This submission is made pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The earnings call was held on Monday, June 1, 2026, and covered the company's financial performance for the fourth quarter and full year ended March 31, 2026.
The transcript has been uploaded to the company's website at the specified URL: https://glenmark.b-cdn.net/gpl_pdfs/Financials/Quarterly/Earnings%20Call%20Transcript%20Q4%20FY26.pdf
This filing follows a previous communication dated May 23, 2026, and serves as formal notification to the stock exchanges to take the transcript on record. The document is signed by Rashmi Khandelwal, Company Secretary & Compliance Officer (ACS - 28839), on behalf of Glenmark Pharmaceuticals Limited.